Arrhythmogenic right ventricular dysplasia:clinical study

Ann Noninvasive Electrocardiol. 2007 Apr;12(2):181-4. doi: 10.1111/j.1542-474X.2007.00158.x.

Abstract

Arrhythmogenic right ventricular dysplasia (ARVD) is a complex arrhythmogenic cardiomyopathy, characterized by a partial or total replacement of the right ventricular myocytes by fatty and fibrous tissue. In this study, we present a case of ARVD in 17 year old girl, who was admitted to the hospital after syncope with ventricular arrhythmia. The echocardiography did not demonstrate structural cardiac abnormalities but the magnetic resonance recently showed thinning of the right ventricular wall. The girl was treated with the lidocaine, amiodarone and next, after radiofrequency catheter ablation she was receiving metoprolol. The girl has remained asymptomatic for four years of follow-up.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmogenic Right Ventricular Dysplasia / diagnosis*
  • Arrhythmogenic Right Ventricular Dysplasia / therapy*
  • Catheter Ablation
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Echocardiography
  • Electrocardiography
  • Female
  • Humans
  • Lidocaine / therapeutic use
  • Magnetic Resonance Imaging
  • Metoprolol / therapeutic use

Substances

  • Anti-Arrhythmia Agents
  • Lidocaine
  • Metoprolol
  • Amiodarone